发明授权
US4868113A Recombinant DNA vector encoding human endothelial cell growth factor
失效
编码人内皮细胞生长因子的重组DNA载体
- 专利标题： Recombinant DNA vector encoding human endothelial cell growth factor
- 专利标题（中）： 编码人内皮细胞生长因子的重组DNA载体
-
申请号： US835594申请日： 1986-03-03
-
公开(公告)号： US4868113A公开(公告)日： 1989-09-19
- 发明人: Michael Jaye , Wilson Burgess , Thomas Maciag , William Drohan
- 申请人： Michael Jaye , Wilson Burgess , Thomas Maciag , William Drohan
- 申请人地址： PA King of Prussia
- 专利权人： Rorer Biotechnology, Inc.
- 当前专利权人： Rorer Biotechnology, Inc.
- 当前专利权人地址： PA King of Prussia
- 主分类号： C12N15/09
- IPC分类号： C12N15/09 ; A61K38/00 ; A61K38/27 ; A61P17/00 ; A61P43/00 ; C07H21/04 ; C07K14/00 ; C07K14/50 ; C07K14/52 ; C12N1/19 ; C12N1/20 ; C12N1/21 ; C12N5/10 ; C12N15/18 ; C12N15/24 ; C12N15/74 ; C12P21/02 ; C12R1/125 ; C12R1/19 ; C12R1/91
摘要：
Endothelial cell growth factor is achieved through the application of recombinant DNA technology to prepare cloning vehicles encoding the ECGF protein and procedures are disclosed for recovering ECGF protein essentially free of other proteins of human origin. The product is useful for, among other purposes, diagnostic applications and as potential in the treatment of damaged blood vessels or other endothelial cell-line structures.
信息查询
IPC分类:
